| 000 | 01125 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512024045.0 | ||
| 264 | 0 | _c19881201 | |
| 008 | 198812s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(88)90101-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLammer, E J | |
| 245 | 0 | 0 |
_aEmbryopathy in infant conceived one year after termination of maternal etretinate. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 1988 |
||
| 300 |
_a1080-1 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAbnormalities, Drug-Induced _xetiology |
| 650 | 0 | 4 |
_aAbnormalities, Multiple _xchemically induced |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aEtretinate _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMaternal-Fetal Exchange |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8619 _gp. 1080-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(88)90101-8 _zAvailable from publisher's website |
| 999 |
_c2909155 _d2909155 |
||